The world's first basic research institute for childhood neurological diseases opened in Houston, Texas and is part of the Texas Children's Hospital. Some of the research the new research insitute will focus on includes childhood neurological diseases such as autism, epilepsy, Rett syndrome, cerebral palsy, ataxias and Batten disease. More details about the new institute are provided in the press release below.
A new study reveals caffeine therapy appears to have benefits for healthy brain development in children born prematurely. Researchers report preterm babies given caffeine therapy had better cognitive scores, reduced odds of cerebral palsy and less hearing impairments as toddlers.
Researchers have identified a molecule in white matter that prevents the brain from repairing itself following injury. By blocking the production of the molecule, researchers say it may allow an effective pathway for neuroregeneration.
Researchers report a protein called estrogen receptor α is higher in females, providing them with stronger protection from hypoxic ischemic encephalopathy.
According to researchers, even before a preterm infant is born, they may have alterations in the brain's neural networks that could contribute to neurodevelopmental disorders.
A collaborative effort aims to provide a new method of communication for people with cerebral palsy.
The development of fine motor skill could take longer than previously thought, according to a new study.
Researchers discovered a novel molecular target for the design of drugs which could be safer and more effective for multiple sclerosis, as well as other disorders associated with the loss of white matter in the brain.
Understanding how babies learn to walk may help to improve rehabilitation treatments for those with cerebral palsy and spinal cord injuries.
Mothers who were prescribed macrolide antibiotics, including erythromycin and azithromycin, early in pregnancy had an increased risk of their child being born with malformations, specifically cardiovascular malformations. However, researchers found no link between exposure to these antibiotics and an increased risk of neurodevelopmental disorders.
A team of scientists from Johns Hopkins and elsewhere have developed nano-devices that successfully cross the brain-blood barrier and deliver a...
Scientists report researchers are now on the threshold of human application of stem cell therapies for a class of neurological diseases known as myelin disorders – a long list of diseases that include conditions such as multiple sclerosis, white matter stroke, cerebral palsy, certain dementias, and rare but fatal childhood disorders called pediatric leukodystrophies.